1-Cyclopropyl-6-fluoro-7-[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid(CAS: 112398-08-0)

This compound requires adherence to GHS classification for hazardous chemicals, including safety data sheets (SDS) and proper labeling. For manufacturing and import/export, it must comply with REACH regulations, ensuring that it is registered if the annual tonnage threshold is exceeded. Additionally, FDA and EPA may have specific requirements for its use in pharmaceuticals and environmental handling, respectively.

While this compound is specific, there are similar quinoline derivatives that can serve as alternatives. Common substitutes include 1-cyclopropylquinoline and 1,4-dihydro-3-quinolinecarboxylic acid. These alternatives can be synthesized using analogous reagents and conditions, providing similar functionalities.

The compound shows increasing interest in pharmaceutical research, particularly in the development of anti-inflammatory and anticancer drugs. Market trends indicate growing demand due to its unique biological activity, driving further research and development efforts. However, price fluctuations and supply chain considerations impact its availability.

Waste containing this compound should be collected and stored in appropriate containers, ensuring that it is neutralized or detoxified before disposal. Incineration is a common method, but professional waste disposal services are recommended to ensure compliance with environmental regulations. Proper handling involves wearing personal protective equipment and following safety protocols to prevent environmental contamination and health risks.